FdaApplication
ANDA 208741
Identifiers
- fda_app_no: ANDA208741
Properties
| Property | Value |
|---|---|
| applicant_name | LUPIN INC |
| application_type | ANDA |
| approval_date | 2023-08-11 |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 50MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 100MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 75MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 200MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 150MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 80MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 120MG BASE | TABLET, DELAYED RELEASE;ORAL |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 60MG BASE | TABLET, DELAYED RELEASE;ORAL |
8 products